Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer
CA-125 has been a valuable marker for the follow-up of ovarian cancer patients but it is not sensitive enough to be used as diagnostic marker. We had already used secretomic methods to identify proteins differentially secreted by serous ovarian cancer cells compared to healthy ovarian cells. Here, w...
Main Authors: | Marianne Kramer, Sandra Pierredon, Pascale Ribaux, Jean-Christophe Tille, Patrick Petignat, Marie Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/208017 |
Similar Items
-
Tenascin-X—Discovery and Early Research
by: Walter L. Miller
Published: (2021-01-01) -
The expression and role of the extracellular matrix protein tenascin in ovarian cancer
by: Wilson, Katherine Elizabeth
Published: (1997) -
Secretome-based identification of novel candidate markers for epithelial ovarian cancer detection
by: Ya Fei Tsai, et al.
Published: (2012) -
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker
by: Sophie Liot, et al.
Published: (2020-05-01) -
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers
by: Ismaïl Hendaoui, et al.
Published: (2021-02-01)